Literature DB >> 11043160

Diet and compliance in phenylketonuria.

A MacDonald1.   

Abstract

UNLABELLED: In phenylketonuria, compliance and diet is a difficult issue; it is hard to quantify and is under-researched. It is influenced by many factors. Failure to consume prescribed quantity of protein substitute has been commonly reported and is probably affected by their acceptability, format and timing of administration. There are few reports documenting actual phenylalanine intake and blood phenylalanine control, but it is possible that the more rigorous systems for allocation of phenylalanine are associated with worse compliance. The dry, hard and insipid nature of many low protein products may lead to their under usage and consequent boredom and hunger. The diet becomes increasingly harder to maintain as children grow older and seek fewer constraints in their meals.
CONCLUSION: In phenylketonuria, encouraging adherence to diet requires continual education, reinforcement and support from the family and professionals within the support team.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11043160     DOI: 10.1007/pl00014375

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  32 in total

1.  Behavioural factors related to metabolic control in patients with phenylketonuria.

Authors:  M R Crone; F J van Spronsen; K Oudshoorn; J Bekhof; G van Rijn; P H Verkerk
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  A randomized, placebo-controlled, double-blind trial of supplemental docosahexaenoic acid on cognitive processing speed and executive function in females of reproductive age with phenylketonuria: A pilot study.

Authors:  S H L Yi; J A Kable; M L Evatt; R H Singh
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2011-10-14       Impact factor: 4.006

3.  Nutritional Changes and Micronutrient Supply in Patients with Phenylketonuria Under Therapy with Tetrahydrobiopterin (BH(4)).

Authors:  A G Thiele; J F Weigel; B Ziesch; C Rohde; U Mütze; U Ceglarek; J Thiery; A S Müller; W Kiess; S Beblo
Journal:  JIMD Rep       Date:  2012-10-17

4.  Nutritional Consequences of Adhering to a Low Phenylalanine Diet for Late-Treated Adults with PKU : Low Phe Diet for Adults with PKU.

Authors:  Ingrid Wiig; Kristina Motzfeldt; Elin Bjørge Løken; Bengt Frode Kase
Journal:  JIMD Rep       Date:  2012-07-01

5.  Dietary protein counting as an alternative way of maintaining metabolic control in phenylketonuria.

Authors:  A L Sweeney; R M Roberts; J M Fletcher
Journal:  JIMD Rep       Date:  2011-09-16

6.  Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.

Authors:  Emily A Sawin; Sangita G Murali; Denise M Ney
Journal:  Mol Genet Metab       Date:  2014-02-08       Impact factor: 4.797

Review 7.  Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuria.

Authors:  Sandra C van Calcar; Denise M Ney
Journal:  J Acad Nutr Diet       Date:  2012-08       Impact factor: 4.910

Review 8.  Nutritional management of PKU with glycomacropeptide from cheese whey.

Authors:  D M Ney; S T Gleason; S C van Calcar; E L MacLeod; K L Nelson; M R Etzel; G M Rice; J A Wolff
Journal:  J Inherit Metab Dis       Date:  2008-10-29       Impact factor: 4.982

9.  Blood phenylalanine concentrations in patients with PAH-deficient hyperphenylalaninaemia off diet without and with three different single oral doses of tetrahydrobiopterin: assessing responsiveness in a model of statistical process control.

Authors:  M Lindner; G Gramer; S F Garbade; P Burgard
Journal:  J Inherit Metab Dis       Date:  2009-06-10       Impact factor: 4.982

10.  Does maternal knowledge impact blood phenylalanine concentration in Turkish children with phenylketonuria?

Authors:  H Gokmen Ozel; T Kucukkasap; G Koksal; H S Kalkanoglu Sivri; A Dursun; A Tokatli; T Coskun
Journal:  J Inherit Metab Dis       Date:  2008-06-27       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.